[Clinical experience with the new vasoactivator Dusodril. Results of clinical tests and a double-blind experiment].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D005021:Ethylamines / Q000627:therapeutic use; D005260:Female; D005663:Furans / Q000627:therapeutic use*; D005684:Gait / Q000187:drug effects; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007383:Intermittent Claudication / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009281:Naphthalenes / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy; D010919:Placebos; D011422:Propionates / Q000627:therapeutic use
D005021:Ethylamines; D005663:Furans; D009281:Naphthalenes; D010919:Placebos; D011422:Propionates
Klinische Erfahrungen mit dem neuen Gefässaktivator Dusodril. Ergebnisse der klinischen Prüfung und eines Dippelblindversuches.